Saint Louis Encephalitis Virus, Brazil

Total Page:16

File Type:pdf, Size:1020Kb

Saint Louis Encephalitis Virus, Brazil LETTERS the present study, PARV4 and PARV5 4. Baylis SA, Shah N, Minor PD. Evaluation Amazon Basin. Subsequently, the have been identified in blood samples of different assays for the detection of virus was repeatedly isolated from ani- parvovirus B19 DNA in human plasma. J obtained from persons from the United Virol Methods. 2004;121:7–16. mals and arthropods in the Amazon Kingdom. For parvovirus B19, there is 5. Fryer JF, Kapoor A, Minor PD, Delwart region and São Paulo state (3). evidence of persistent virus infection, E, Baylis SA. Novel parvovirus and relat- Nonetheless, isolation of SLEV from at low levels, in bone marrow of previ- ed variant in human plasma. Emerg Infect humans is rare; only 2 isolates from Dis. 2006;12:151–4. ously exposed persons (7) and in plas- 6. Padley DJ, Lucas SB, Saldanha J. humans were described before 2005. ma of immunocompromised and Elimination of false-negative hepatitis C Each isolate was from a patient who immunocompetent persons (8,9). virus RNA results by removal of had jaundice and febrile illness with- There is also evidence for the lifelong inhibitors in cadaver-organ donor blood out any neurologic symptoms (1,3). specimens. Transplantation. persistence of parvovirus B19 (geno- 2003;76:432–4. Recently in São Paulo, SLEV was iso- types 1 and 2) in tissues such as skin 7. Heegaard ED, Petersen BL, Heilman CL, lated from a patient who had an incor- and synovia (10). PARV4 and PARV5 Hornsleth A. Prevalence of parvovirus rect diagnosis of dengue fever (2,4). virus genomes share only limited B19 and parvovirus V9 DNA and antibod- Despite the rare isolation of ies in paired bone marrow and serum sam- homology with parvovirus B19 (<30% ples from healthy individuals. J Clin SLEV from humans, antibodies to this amino acid similarity). Although they Microbiol. 2002;40:933–6. virus have been found in ≈5% of stud- have been detected in blood and plas- 8. Flunker G, Peters A, Wiersbitzky S, ied populations in the north and ma, nothing is known about the role of Modrow S, Seidel W. Persistent par- southeast regions of Brazil. However, vovirus B19 infections in immunocom- these viruses in human disease or their promised children. Med Microbiol because of antibody cross-reactivity ability to persist in infected persons, Immunol (Berl). 1998;186:189–94. among different flaviviruses and the healthy or otherwise. Further studies 9. Lefrere JJ, Servant-Delmas A, Candotti fact that this population is vaccinated will be required to determine the D, Mariotti M, Thomas I, Brossard Y, et against yellow fever and exposed to al. Persistent B19 infection in immuno- prevalence of PARV4 and PARV5 in competent individuals: implications for dengue virus (DENV), such results healthy persons compared with its transfusion safety. Blood. should be interpreted carefully. prevalence in those with chronic infec- 2005;106:2890–5. Nevertheless, in these areas, SLEV tions and at high risk, such as IVDUs, 10. Norja P, Hokynar K, Aaltonen LM, Chen may circulate and infect humans, R, Ranki A, Partio EK, et al. Bioportfolio: and to investigate the nature of persist- lifelong persistence of variant and proto- although most infections are undiag- ence of these novel viruses. typic erythrovirus DNA genomes in nosed (1,3,5). human tissue. Proc Natl Acad Sci U S A. In contrast to previous instances Jacqueline F. Fryer,* 2006;103:7450–3. in which the disease was detected in Sebastian B. Lucas,† only 1 patient, we describe the first Address for correspondence: Sally A. Baylis, David Padley,* community outbreak of SLEV in Division of Virology, National Institute for and Sally A. Baylis* Brazil. The outbreak was detected in Biological Standards and Control, Blanche *National Institute for Biological Standards São José do Rio Preto (population Lane, South Mimms, Potters Bar, and Control, Potters Bar, United Kingdom; 400,000), in northwest São Paulo and †Saint Thomas’ Hospital, London, Hertfordshire, EN6 3QG, United Kingdom; state. This outbreak was concurrent United Kingdom email: [email protected] with a large outbreak of DENV References serotype 3 (DENV-3), which occurred during the first half of 2006, with 1. Tattersall P. The evolution of parvovirus >15,000 possible cases reported to taxomomy. In: Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR, edi- public health authorities. During this tors. Parvoviruses. London: Hodder time, we were involved in an epidemi- Arnold; 2006. p. 5–14. ologic study to monitor the disease. 2. Jones MS, Kapoor A, Lukashov VV, Saint Louis We tested ≈250 samples for DENV, Simmonds P, Hecht F, Delwart E. New and 65% were positive. We tested for DNA viruses identified in patients with Encephalitis Virus, acute viral infection syndrome. J Virol. SLEV only those patients who were in 2005;79:8230–6. Brazil our hospital or those who were 3. Allander T, Tammi MT, Eriksson M, To the Editor: Saint Louis referred to us for SLEV testing after Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human par- encephalitis virus (SLEV), a member an initial diagnosis of SLEV or vovirus by molecular screening of respi- of the Flaviviridae family, is widely DENV. The protocol approved by our ratory tract samples. Proc Natl Acad Sci U dispersed in the Americas (1,2). In ethical committee allowed us to test S A. 2005;102:12891–6. Brazil, SLEV was first isolated in the only samples from these patients 1960s from a pool of mosquitoes at the (process no. 300/2004). 176 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 1, January 2007 LETTERS We used a multiplex nested lence of antibodies in the Brazilian In Argentina, SLEV has been iso- reverse transcription–PCR (RT-PCR) population (1,3,6) suggests that SLEV lated several times from animals (8). assay to identify the most common infections are being misdiagnosed; its In some regions, SLEV seropreva- flaviviruses in Brazil (DENV-1, importance is underestimated. Brazil lence in humans is ≈13% (9), but the DENV-2, DENV-3, yellow fever has no SLEV surveillance programs, number of documented human infec- virus) as well as DENV-4, Ilheus and health professionals do not usual- tions is small (10). These findings virus, Iguape virus, Rocio virus, and ly consider SLEV among their differ- indicate either that SLEV is more SLEV. Of 54 samples (49 serum and 5 ential diagnoses. This SLEV outbreak prevalent than reported or that SLEV cerebrospinal fluid [CSF]) that were was detected in a large urban center is reemerging. The Brazilian cases negative for DENV and yellow fever and was not specifically linked to may parallel the situation in virus, SLEV RNA was detected in 6 patients who dwell in pockets of trop- Argentina. (4 serum and 2 CSF) (6). RT-PCR ical forests, as previously reported Our results clearly indicate an results were negative for all other test- (1–4). SLEV outbreak among this local pop- ed flaviviruses. Sequences of the This outbreak may represent the ulation in Brazil. This outbreak differs amplified SLEV cDNAs from the 2 first time that hemorrhagic signs have from isolated infections previously CSF samples were determined by been linked to SLEV infections. described and indicates that this dis- using an ABI377 automated SLEV-associated hemorrhagic mani- ease may be more prevalent in Brazil. sequencer (Applied Biosystems, festations have not been reported in In fact, the number of samples tested Foster City, CA, USA). The resulting the literature. However, of our 6 for SLEV during this DENV outbreak sequences (GenBank accession nos. SLEV-infected patients, 3 had hemor- was relatively small. Had more sam- DQ836336 and DQ836337) were rhagic signs. Substantiating a causal ples been investigated, more cases of identical and showed 96% homology link between SLEV infection and SLEV infection might have been to an Argentinean SLEV isolate such clinical manifestations is diffi- found. A more comprehensive epi- (AY6-32544). All 6 SLEV-infected cult because DENV is endemic in the demiologic study is required to fully patients had an initial diagnosis of studied region (7). Possibly, SLEV- assess the magnitude of SLEV infec- dengue fever or viral encephalitis; 3 infected patients with hemorrhagic tion in Brazil. had a diagnosis of viral meningoen- signs may have been previously cephalitis, and the other 3 had signs of infected by DENV. No reports have This work was supported by grants hemorrhagic disease (Table). linked hemorrhagic manifestations to from Conselho Nacional de Desen- Dengue is widely disseminated in sequential DENV and SLEV infec- volvimento Científico e Tecnológico Brazil and causes large outbreaks tions; this possible link needs to be (0401396/2004-5) to M.L.N. and Fundação almost every year. The high preva- carefully evaluated. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 1, January 2007 177 LETTERS de Amparo à Pesquisa do Estado de São 4. Santos CL, Sallum MA, Franco HM, Cryptococcus gattii Paulo (FAPESP) (04/11098-2, 06/0170-9, Oshiro FM, Rocco IM. Genetic character- ization of St. Louis encephalitis virus iso- Risk for Tourists and 03/03682-3) to M.L.N., F.C.N., and lated from human in São Paulo, Brazil. L.T.M.F., respectively. R.V.M.B. and Mem Inst Oswaldo Cruz. Visiting Vancouver I.L.S.C. received fellowships from FAPE- 2006;101:57–63. Island, Canada SP (grants 05/03260-7 and 06/00179-7). 5. de Sousa Lopes O, de Abreu Sacchetta L, Coimbra TL, Pereira LE. Isolation of St. This work was supported by the Viral Louis encephalitis virus in South Brazil. To the Editor: An unprecedented Diversity Genetic Network (VGDN- Am J Trop Med Hyg. 1979;28:583–5.
Recommended publications
  • Saint Louis Encephalitis Virus and Other Arboviruses in the Differential Diagnosis for Dengue
    Revista da Sociedade Brasileira de Medicina Tropical 47(5):541-542, Sep-Oct, 2014 http://dx.doi.org/10.1590/0037-8682-0197-2014 Editorial Saint Louis encephalitis virus and other arboviruses in the differential diagnosis for dengue Luiz Tadeu Moraes Figueiredo[1] [1]. Centro de Pesquisa em Virologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP. Brazil is a tropical country with a wide variety of flora and SLEV-seropositive by an immunoglobulin G-enzyme-linked fauna that includes many arthropods, especially mosquitoes and immunosorbent assay (IgG-ELISA), and these findings were midges. This ecological diversity facilitates the maintenance confirmed by a highly specific neutralization test. In the following of arboviral cycles and the emergence of novel arboviral year, during a widespread dengue type 3 epidemic, six patients pathogens. Indeed, many outbreaks attributable to zoonotic tested positive for SLEV in the City of São José do Rio Preto3,4. arboviruses such as Oropouche, Mayaro, Rocio virus (ROCV), Recently, a patient from Ribeirão Preto who presented with acute Saint Louis encephalitis virus (SLEV) and yellow fever virus febrile illness was also found to be SLEV-positive5. have been seen in the recent past. Furthermore, due to the In contrast to SLEV, ROCV has only been isolated in the increase in international travel, arboviruses present in other southeastern region of Brazil in the 1970s during a large-scale American countries, such as the emergent viruses West Nile outbreak of encephalitis that resulted in many fatalities. During and Chikungunya, have already been introduced, or could this outbreak, ROCV was isolated from 3 sources, a patient, be introduced to this region in the future.
    [Show full text]
  • (SLE) Frequently Asked Questions What Is Saint Louis Encephalitis?
    Saint Louis Encephalitis (SLE) Frequently Asked Questions What is Saint Louis encephalitis? Saint Louis encephalitis (SLE) is a type of viral encephalitis (inflammation or swelling of the brain) caused by the Saint Louis encephalitis virus. The SLE virus is transmitted to humans by mosquitoes. This virus normally only circulates between birds and mosquitoes. Human‐biting mosquitoes can become infected, however, and can transmit this disease to people. These mosquitoes tend to live and breed in urban and suburban areas; most human cases are also found in these areas. Because of the life cycle of the mosquitoes that transmit SLE virus, most SLE infections occur in the late summer and in the fall. Saint Louis encephalitis is found throughout the United States, including Georgia. What are the symptoms of SLE? Most people do not become ill when a mosquito infected with the SLE virus bites them. People who do experience symptoms will start to feel ill approximately 5‐15 days after the mosquito bite. Most people who experience symptoms will only suffer from headaches or a mild flu‐like illness with muscle aches, weakness, or vomiting. A small number of persons may develop encephalitis or aseptic meningitis (inflammation/swelling of the protective covering of the brain and spinal cord), and may experience symptoms such as confusion, coma, and possibly death. How likely am I to have serious illness resulting from SLE infection? Less than 1% of persons infected with Saint Louis encephalitis virus will show symptoms. In children less than 10 years old, only 1 child out of 800 will experience symptoms.
    [Show full text]
  • Saint Louis Encephalitis (SLE)
    Encephalitis, SLE Annual Report 2018 Saint Louis Encephalitis (SLE) Saint Louis Encephalitis is a Class B Disease and must be reported to the state within one business day. St. Louis Encephalitis (SLE), a flavivirus, was first recognized in 1933 in St. Louis, Missouri during an outbreak of over 1,000 cases. Less than 1% of infections manifest as clinically apparent disease cases. From 2007 to 2016, an average of seven disease cases were reported annually in the United States. SLE cases occur in unpredictable, intermittent outbreaks or sporadic cases during the late summer and fall. The incubation period for SLE is five to 15 days. The illness is usually benign, consisting of fever and headache; most ill persons recover completely. Severe disease is occasionally seen in young children but is more common in adults older than 40 years of age, with almost 90% of elderly persons with SLE disease developing encephalitis. Five to 15% of cases die from complications of this disease; the risk of fatality increases with age in older adults. Arboviral encephalitis can be prevented by taking personal protection measures such as: a) Applying mosquito repellent to exposed skin b) Wearing protective clothing such as light colored, loose fitting, long sleeved shirts and pants c) Eliminating mosquito breeding sites near residences by emptying containers which hold stagnant water d) Using fine mesh screens on doors and windows. In the 1960s, there were 27 sporadic cases; in the 1970s, there were 20. In 1980, there was an outbreak of 12 cases in New Orleans. In the 1990s, there were seven sporadic cases and two outbreaks; one outbreak in 1994 in New Orleans (16 cases), and the other in 1998 in Jefferson Parish (14 cases).
    [Show full text]
  • West Nile Virus Encephalitis Since The
    West Nile Virus Encephalitis Since the first United States occurrence of West Nile Virus (WNV) in New York in 1999, the virus has spread all the way down the East Coast, and as far west as Colorado and Nebraska. This Arbovirus belongs to the Japanese Encephalitis group along with Saint Louis Encephalitis. Arboviruses are vectored by mosquitoes; birds are the natural reservoir hosts. In other words, the virus replicates in birds, and is transmitted to others when a mosquito bites an infected bird and then passes the virus along during its next blood meal. Horses and humans are dead end hosts, meaning that they are not part of the viral replication cycle, and cannot directly pass the disease on to others. West Nile Virus produces lesions in the gray matter of the mid-brain, hind- brain, and spinal cord. Lesions tend to increase in severity the closer they are to the hindquarters. Lesions can be symmetrical or asymmetrical, effecting both or only one side of the horse. They can also be in more than one location, so combinations of clinical signs may vary. Clinical signs of West Nile Virus include fever (in about 60% of cases), muscle weakness, and neurologic problems including ataxia (staggering or incoordination), abnormal mental state (depression, lethargy, behavior changes), and muscle fasiculations (trembling) of the head and neck. Some cranial nerves may also be involved producing drooping of the facial muscles, difficulty swallowing, and problems with normal tongue function. Any number and combination of these signs is possible. Prognosis is variable, and depends on severity of clinical signs, and prompt veterinary attention.
    [Show full text]
  • Eastern Equine Encephalitis (EEE), Lacrosse Encephalitis (LAC), and West Nile Virus (WNV), Are Also Found in Georgia
    Georgia Department of Human Resources (DHR) Division of Public Health Saint Louis Encephalitis (SLE) Frequently Asked Questions Georgia Department of Human Resources, Division of Public Health Updated 03/21/05 What is Saint Louis encephalitis? Saint Louis encephalitis (SLE) is a type of viral encephalitis (inflammation or swelling of the brain) caused by the Saint Louis encephalitis virus. The SLE virus is transmitted to humans by mosquitoes. This virus normally only circulates between birds and mosquitoes. Human-biting mosquitoes can become infected, however, and can transmit this disease to people. These mosquitoes tend to live and breed in urban and suburban areas; most human cases are also found in these areas. Because of the life cycle of the mosquitoes that transmit SLE virus, most SLE infections occur in the late summer and in the fall. Saint Louis encephalitis is found throughout the United States, including Georgia. What are the symptoms of SLE? Most people do not become ill when a mosquito infected with the SLE virus bites them. People who do experience symptoms will start to feel ill approximately 5-15 days after the mosquito bite. Most people who experience symptoms will only suffer from headaches or a mild flu-like illness with muscle aches, weakness, or vomiting. A small number of persons may develop encephalitis or aseptic meningitis (inflammation/swelling of the protective covering of the brain and spinal cord), and may experience symptoms such as confusion, coma, and possibly death. How likely am I to have serious illness resulting from SLE infection? Less than 1% of persons infected with Saint Louis encephalitis virus will show symptoms.
    [Show full text]
  • Eastern Equine Encephalitis (EEE)
    Infectious Disease Epidemiology Section Office of Public Health, Louisiana Dept of Health & Hospitals 800-256-2748 (24 hr number) – (504) 568-5005 www.oph.dhh.state.la.us Eastern Equine Encephalitis (EEE) Revised 12/12/2004 Epidemiology Eastern Equine Encephalitis (EEE) virus is an alphavirus belonging to the Togaviridae family, occurring in the eastern half of the United States. Other alphaviruses that can cause human infection include Western and Venezuelan equine en- cephalitis viruses. All of these viruses are transmitted to humans through the bite of an infected mosquito. Like the West Nile (WNV) and St. Louis (SLE) viruses, the natural reservoir for the virus is birds and the virus is trans- mitted from bird to bird through mosquito bites. EEE surveillance in Louisiana includes the collection of mosquito pools and the use of sentinel chickens. Since a large number of horse cases and deaths usually precedes the identification of a human case, veterinarians are asks to report any horses exhibiting suspicious signs consistent with EEE to the State Vet- erinarian’s Office and to submit serum for testing. The most important mosquito in maintaining the EEE enzootic between birds is Culiseta melanura, this often occurs in coastal areas and freshwater swamps. Since this species rarely bites humans, Cs. inoronata, Cx. quinquefasciatus (the Southern House Mosquito), Ae. albopictus (the Asian Tiger mosquito), Ae. sollicitans (the tan salt marsh mosquito), Ae. vexans and Coquillettidia perturbans, are more important in the transmission of the virus to humans and horses. In Louisiana, Culex quinquefasciatus, the Southern House Mosquito, is also the main vector of WNV and SLE.
    [Show full text]
  • Ebolavirus and Other Filoviruses
    CTMI (2007) 315:363–388 © Springer-Verlag Berlin Heidelberg 2007 Ebolavirus and Other Filoviruses J. P. Gonzalez 1 ( *ü ) · X. Pourrut 1 · E. Leroy 1 1 Fundamentals and Domains of Disease Emergence Research Unit, RU178 , Institute for Research Development, IRD , Paris , France [email protected] 1 Introduction ..................................................................................................... 364 2 Ebola Virus and Hosts ..................................................................................... 365 2.1 A Variety of Incidental Hosts and an Elusive Reservoir .................................. 365 2.2 Animal Species Affected by Ebola Virus .......................................................... 368 2.3 The Discovery of an Elusive Host: Ebola Virus Reservoirs in Africa .............. 370 3 Toward Understanding a Complex Natural Cycle and the Origin of Primate Ebola Epidemics ................................................................................ 373 4 Other Members of the Filovirus Family ........................................................ 376 4.1 Marburg Virus ................................................................................................... 378 4.2 The Phylogeographic Enigma of Reston Virus ................................................ 378 5 Conclusions ...................................................................................................... 379 5.1 Bats, an Underappreciated Reservoir Host for Zoonotic Viruses ................... 379 5.2 Bats and Human Disease
    [Show full text]
  • Preparedness and Response for Chikungunya Virus: Introduction in the Americas Washington, D.C.: PAHO, © 2011
    O P S N N O PR O V United States of America Washington, D.C. 20037, 525 Twenty-third Street, N.W., I S M A U L U N T D E I O H P A PAHO/CDC PREparEDNESS AND RESPONSE FOR CHIKUNGUNYA VIRUS INTRODUCTION IN THE AMERICAS Chikungunya Virus Chikungunya Introduction in theAmericas in Introduction Preparedness andResponse for Preparedness and Response for Chikungunya Virus Introduction in the Americas S A LU O T R E P O P A P H S O N I O D V I M U N PAHO HQ Library Cataloguing-in-Publication Pan American Health Organization Preparedness and Response for Chikungunya Virus: Introduction in the Americas Washington, D.C.: PAHO, © 2011 ISBN: 978-92-75-11632-6 I. Title 1. VECTOR CONTROL 2. COMMUNICABLE DISEASE CONTROL 3. EPIDEMIOLOGIC SURVEILLANCE 4. DISEASE OUTBREAKS 5. VIRUS DISEASE - transmission 6. LABORATORY TECHNIQUES AND PROCEDURES 7. AMERICAS NLM QX 650.DA1 The Pan American Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and inquiries should be addressed to Editorial Services, Area of Knowledge Management and Communications (KMC), Pan American Health Organization, Washington, D.C., U.S.A. The Area for Health Surveillance and Disease Prevention and Control, Project for Alert and Response and Epidemic Diseases, at (202) 974-3010 or via email at [email protected], will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. ©Pan American Health Organization, 2011.
    [Show full text]
  • 31St Brazilian Online Society for Virology (SBV) 2020 Annual Meeting
    viruses Conference Report 31st Brazilian Online Society for Virology (SBV) 2020 Annual Meeting Luciana Barros de Arruda 1,* , Fabrício Souza Campos 2 ,Jônatas Santos Abrahão 3, Flávio Guimarães da Fonseca 3 , João Pessoa Araújo Junior 4 and Fernando Rosado Spilki 5,* 1 Laboratório de Genética e Imunologia das Infecções Virais, Depto de Virologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ 21941-902, Brazil 2 Bioinformatics and Biotechnology Laboratory, Campus de Gurupi, Universidade Federal do Tocantins (UFT), Gurupi, TO 77410-570, Brazil; [email protected] 3 Department of Microbiology, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MT 31270-901, Brazil; [email protected] (J.S.A.); [email protected] (F.G.d.F.) 4 Institute of Biotechnology, Universidade Estadual Paulista (UNESP), Botucatu, SP 18607-440, Brazil; [email protected] 5 One Health Laboratory, Federação de Estabelecimentos de Ensino Superior em Novo Hamburgo (FEEVALE), Novo Hamburgo, RS 93525-075, Brazil * Correspondence: [email protected] (L.B.d.A.); [email protected] (F.R.S.) Abstract: The year 2020 was profoundly marked by the emergence and spread of SARS-CoV-2, causing COVID-19, which represents the greatest pandemic of the 21st century until now, and a major challenge for virologists in the scientific and medical communities. Increased numbers of SARS-CoV-2 infection all over the world imposed social and travel restrictions, including avoidance of face-to-face scientific meetings. Therefore, for the first time in history, the 2020 edition of the Brazilian Society of Virology (SBV) congress was totally online.
    [Show full text]
  • FIRST HUMAN CASE of SAINT LOUIS ENCEPHALITIS VIRUS DETECTED in STANISLAUS COUNTY MODESTO, CA (December 6, 2017) – a Male in His 70’S Is the First Confirmed Human St
    HEALTH SERVICES AGENCY Administration 830 Scenic Drive P.O. Box 3271 Modesto, CA 95353 Phone: (209) 558-7163 Fax: (209)558-7123 www.hsahealth.org NUMBER: 17-21 DATE: December 6, 2017 FOR RELEASE: Immediate CONTACT: Anuj Bhatia Phone: (209) 558-6833 FIRST HUMAN CASE OF SAINT LOUIS ENCEPHALITIS VIRUS DETECTED IN STANISLAUS COUNTY MODESTO, CA (December 6, 2017) – A male in his 70’s is the first confirmed human St. Louis encephalitis virus (SLEV) infection in Stanislaus County for 2017, announced Dr. Julie Vaishampayan, Stanislaus County Public Health Officer. “He had symptoms and was tested in September; confirmatory testing was performed first by the California Department of Public Health followed by the Centers for Disease Control and Prevention.” This is the second person in California testing positive for the virus in 2017 The virus was identified in mosquitoes in Stanislaus County in August of this year, the first detection in over four decades. To date in 2017, SLEV has been detected in mosquitoes in 14 California counties. SLEV is transmitted to humans by the bite of an infected mosquito. Most people infected with SLEV have no apparent illness. Initial symptoms of those who become ill may include fever, headache, nausea, vomiting, and tiredness. Severe neuroinvasive disease (often involving encephalitis, an inflammation of the brain) occurs more commonly in older adults. Like West Nile virus, there is no vaccine or specific treatment for SLEV infection. While mosquito activity has dramatically decreased due to colder temperatures, Stanislaus County residents can still protect themselves and their families by following these simple steps: DEET – Apply insect repellent containing DEET, picaridin, oil of lemon eucalyptus or IR 3535 according to label instructions to keep mosquitoes from biting you.
    [Show full text]
  • Saint Louis Encephalitis Fact Sheet
    Saint Louis Encephalitis Fact Sheet 1. What is Saint Louis Encephalitis (SLE)? - SLE is a rare, but serious viral infection that is closely related to West Nile Virus. The mosquito-borne virus silently infects bird populations and is then spread from bird to bird by mosquitoes. These infected mosquitoes can also bite humans. The risk of humans getting SLE in Pennsylvania is highest from late July through September when mosquitoes are most abundant. SLE has historically been reported most frequently in the central and eastern United States. 2. What is the disease incubation period in humans? – The time from infection to onset of symptoms of SLE is usually 5 to 15days. 3. What are the symptoms of SLE? - Many persons infected with SLE virus have no apparent illness. People with mild illness often have only a headache and fever. More severe infection is marked by headache, high fever, neck stiffness, stupor, disorientation, coma, tremors, occasional convulsions (especially in infants) and spastic (but rarely flaccid) paralysis. The mortality rate from SLE ranges from 5 to 30%, with higher rates among the elderly. 4. How is SLE diagnosed? A definitive diagnosis of SLE disease requires that specimens are collected for laboratory diagnosis. Blood or spinal fluid can be sent to a laboratory and examined for genetic evidence of the virus, to isolate the virus in culture, or to test for the body’s immune response to the infection (antibody testing). 5. How common is SLE in Pennsylvania? - SLE in the Commonwealth is extremely rare with no human cases having been reported since 1964.
    [Show full text]
  • Florida Department of Health in Volusia County EPI LOG Third Quarter 2013
    Florida Department of Health Volusia County RABIES By Dr. Paul Rehme, DVM, MPH Rabies is a zoonotic disease that continues to pose a significant risk for our population. Although there has not been a Florida acquired human case in the state since 1948, Some bites, especially those that are we continue to see cases in animals at the unprovoked or by high-risk animals, may rate of between one and require immediate PEP. Bites around the two hundred every year. head or neck are considered high priority, By far, the most common and should be reported immediately by animal found with rabies is phone. If there are any questions at all about the raccoon, but it is also the rabies risk for your patients call an seen in foxes, cats, bats; epidemiologist for consultation. and a few dogs. Volusia County has had three reported raccoon cases Providers should report all animal bites to and one cat so far this year. Human cases OOH-Volusia via fax by filling out an Animal BHe Report Form and faxing it to 274-0641. have been prevented by careful follow-up and The form can be downloaded from : http:// appropriate case management to include WNW.ftoridaheaith.gov/chd/volusia/ appropriate use of post-exposure prophylaxis (PEP). Because the disease is almost For previously unvaccinated persons, PEP universally fatal once signs/symptoms are consists of human rabies immunoglobulin seen, this is no time to let down our guard. (HRiG) and four vaccines given on days 0, 3, We must continue to work together to ensure 7, and 14.
    [Show full text]